The appetite for risk in orthopedic medical device companies evolves with their size, reflecting shifts in resources, priorities, and stakeholder expectations.
In my last startup, the CEO drilled into us that we only had ONE ADVANTAGE over the Big Orthos - the ability to take extreme risks each week.
1/ Startup (5 employees, no sales)
With a small team and no significant revenue, risk-taking is a necessity. These companies must innovate boldly, chasing groundbreaking implants or instruments to carve out market space. Limited resources force them to "reach for the stars," betting on high-risk, high-reward projects to attract investors and establish a foothold.
2/ Small Enterprise (50 employees, emerging revenue)
As the company grows to 50 employees with steady revenue, risk-taking becomes more balanced. The focus splits between developing new products to expand the portfolio and supporting existing ones to maintain customer trust. Calculated risks in R&D drive innovation, while early sales provide a cushion to experiment without jeopardizing stability.
3/ Mid-Sized Firm (300 employees, strong single-digit growth)
At 300 employees and consistent revenue growth, the emphasis ...
